Le Lézard
Classified in: Health
Subjects: HEALTH, LIFESTYLE, TRADE SHOWS/SEMINARS/WEBINARS, MISCELLANEOUS, MISCELLANEOUS

Lift&Co. Expo Powers the Future of the Cannabis Industry


Toronto, Ontario, April 12, 2022 (GLOBE NEWSWIRE) -- Tickets are on sale now for Lift&Co. Expo, Canada's no. 1 cannabis conference and trade show, taking place at the Metro Toronto Convention Centre, May 12-15, 2022. As the highly anticipated show draws near, the team behind the scenes reveals noteworthy new features and a schedule of can't-miss content to power the future of Canada's booming cannabis industry.

 Lift&Co. Expo Toronto 2022 includes:?

Lift&Co. Expo 2022 kicks off with the leading educational event of its kind, the Lift Cannabis Business Conference (LCBC), on May 12, 2022. With a speaker list that reads as a who's-who of the modern cannabis industry, topics will focus on forward-thinking insights on Canada and across the globe. Thereafter, Lift&Co. Expo Industry Days on May 13 and 14, which include the CannaVest North Investment Forum, will continue exploring what's new, notable and next in the cannabis industry.

Content highlights include:

Speakers appearing on-stage and leading sessions include:

"Word has traveled fast that the Canadian cannabis market is projected to reach $4.8B in sales in 2022, but that's just a number," says Shawn Pierce, President of MCI Events. "Savvy industry members trust Lift&Co. Expo for the information and future insights they need to make the most of the market. We take this responsibility very seriously, but we also have a lot of fun doing it."

This year, the signature Lift&Co. Expo experience will include plenty of new features and attractions. To name a few: Along with returning Presenting Partner JMCC, new Presenting Partner Greenpoint POS joins the line-up. The new Lift&Co. Expo Discovery Zone will showcase first-time finds in a special section of the exhibition hall filled with hundreds of products, services and innovations. New Budtenders' Masterclasses, plus additional benefits for the hardworking, highly-skilled folks behind the counter. The first-ever Lift&Co. Expo Ambassador Board features 20-plus cannabis industry insiders. Plus, even more giveaways, fresh photo activations and a new expanded capacity after-party venue (to be announced soon).

With dozens of learning opportunities and hundreds of speakers, that's but glimpse at what will be revealed. All this, plus the uniquely irresistible experience that makes Lift&Co. Expo the #1 event with thousands of cannabis retailers, producers, growers, investors, movers and shakers.

Visit liftexpo.ca for more information and to purchase tickets for Lift&Co. Expo Toronto 2022, taking place at the Metro Toronto Convention Centre, May 12-15, 2022. Follow Lift&Co. Expo on Instagram for exclusive content and giveaways leading up to the show.

Attachment



These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: